Nanocovax

It’s unsure when the vaccine gets approval for emergency use.

HLB’s affiliate NextScience holds 10.4% of the Vietnamese vaccine developer Nanogen.

The homegrown Covid-19 vaccine candidate Nanocovax will finish phase 3 clinical trials in August.

The move aims to release the locally-made vaccines in the shortest time, meeting the increasing demand for vaccination in Vietnam.

The Ministry of Health is asked to minimize administrative procedures that hinder vaccine production and to support businesses as much as possible to solve the most concerning issue.

Vietnam is making efforts to have its own Covid-19 vaccines amid the global thin supply.

Ho Chi Minh is conducting a massive testing campaign of more than 5 million residents until July 5.

Vietnam is racing against time to reach 150 million doses of vaccine for 70% of its population.

The license might be issued in the final trial that is expected to last two months from June.